National Vision Holdings, Inc. (EYE) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights several positive factors: raised revenue outlook, expected gross margin expansion, and optimistic customer trends, especially in managed care and premium segments. Despite some deceleration in Q4 growth due to macro uncertainties, the company's strategic initiatives, such as new store openings and CRM platform launch, indicate future growth. Analysts' questions reflected confidence, with no significant competitive losses noted. The positive sentiment is further reinforced by the success of Meta glasses and brand awareness growth. Overall, the company's strong financial metrics and strategic positioning suggest a positive stock price movement.
Key Financial Performance
Adjusted Comparable Store Sales Growth 7.7% year-over-year increase, driven by higher average ticket prices (7.1% increase) due to price increases and a refreshed merchandising mix.
Net Revenue Increased by 7.9% year-over-year, supported by adjusted comparable store sales growth and new store sales.
Adjusted Operating Margin Expanded by 90 basis points year-over-year to 4.1%, supported by higher average ticket prices and leveraging optometrist-related costs.
Adjusted SG&A $242.3 million, leveraged 10 basis points year-over-year despite higher healthcare costs.
Adjusted Operating Income $19.8 million, up from $14.3 million in the prior year, reflecting a 90 basis point increase in adjusted operating margin.
Adjusted EPS Increased to $0.13 per share from $0.12 per share year-over-year, supported by operating income growth.
Cash Balance Approximately $56 million at the end of Q3, with total liquidity of $349.6 million.
Debt Repayment $15 million repaid during the quarter, bringing year-to-date repayment to $94.7 million.
Operating Cash Flow $133.1 million year-to-date, reflecting strong cash generation.
Capital Expenditures $48.4 million year-to-date, primarily for new and existing stores and IT investments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Meta-enabled smart glasses: Initial pilot in 50 stores showed positive consumer uptake. Plan to roll out to an additional 250 locations in Q4.
Premium frames: New premium frames like Lam, Ted Baker, Jimmy Choo, and HUGO Boss introduced, exceeding expectations. Approximately 40% of frames in stores will be priced at or above $99 by year-end, up from 20% last year.
Managed care business: Continues to show strong performance with low teens comp sales growth, driven by positive transaction and ticket trends.
Targeting high-value segments: Focus on managed care customers, progressive lens wearers, and outside Rx customers, leading to healthier business and customer mix.
Digital selling tools: Introduced tools to explain lens benefits and pricing, improving customer experience. Expected to be live in all locations by year-end.
CRM platform: Launched new platform leading to increased customer engagement, higher exam scheduling, and improved reactivation rates.
Cost optimization: Efforts underway to mitigate higher healthcare expenses and improve SG&A leverage.
Pricing strategy: Evolving pricing architecture with new actions on lenses, add-ons, and bundles. Modernized bundled pricing to $95 for lead offer.
Marketing transformation: Launched 'Every Eye Deserves Better' campaign and new CRM platform, resulting in increased unaided awareness and customer engagement.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Health care expenses: The company is facing higher-than-planned health care expenses, which could impact operating margins and overall financial performance.
Cash pay traffic: Decline in cash pay traffic is noted, which could affect revenue growth, especially as managed care traffic offsets this decline.
SG&A leverage: While there is progress in SG&A leverage, ongoing headwinds in health care costs and other expenses could challenge cost optimization efforts.
Pricing strategy: The company is implementing pricing updates, but there is a risk of customer pushback or reduced conversion rates if pricing changes are not well-received.
Store closures: Planned closures of 23 stores in 2025, including 4 in Q4, could impact revenue and market presence in certain areas.
Fleet optimization: Fleet optimization efforts, while aimed at improving efficiency, may lead to short-term disruptions or loss of customer base in affected locations.
Economic conditions: General economic uncertainties could impact consumer spending, particularly in discretionary areas like eyewear.
Health care cost mitigation: Efforts to mitigate health care costs may not fully offset the financial impact, posing a risk to profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations: The company has raised its revenue expectations for the year to $1.97 billion to $1.99 billion, incorporating the benefit of a 53rd week, which is estimated to add approximately $35 million of net revenue.
Adjusted Comparable Store Sales Growth: The company expects adjusted comparable store sales growth of 5% to 6% for the year, calculated on a 52-week comparable basis.
Adjusted Operating Income: The company projects adjusted operating income of $92 million to $98 million for the year, including the benefit of the 53rd week, which is estimated to add approximately $3 million.
Adjusted EPS: The company expects adjusted EPS of $0.63 to $0.71, assuming approximately 81 million weighted average diluted shares outstanding.
Pricing Strategy: The company is executing Q4 pricing updates as part of its multiyear pricing strategy playbook, including adjustments to lenses, lens add-ons, and bundled offers. The lead offer price point is being modernized from $89.95 to $95.
Capital Expenditures: The company has reduced its CapEx guidance to $80 million to $85 million, with certain projects shifting into fiscal 2026. It plans to open 32 new stores in fiscal 2025, with 9 net new stores expected after accounting for closures.
Traffic Trends: The company anticipates traffic trends to remain consistent with year-to-date patterns, with strong traffic from managed care customers offsetting a decline in cash pay traffic.
Gross Margin: Gross margin is expected to expand slightly for fiscal 2025, driven by growth in average ticket and leveraging optometrist-related costs.
Cost Management: The company is focused on disciplined cost management, including cost-out actions and mitigation strategies to offset healthcare cost headwinds and investments in associate incentive programs.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What signals are you looking for to ensure you're not going too far with merchandising changes, and when do you think traffic will inflect?
A:The company monitors NPS and conversion rates from exam to purchase to ensure they are not pushing too far. They are encouraged by higher-than-expected adoption of higher price point items by cash pay consumers and better-than-expected inventory turns of higher value frames. Traffic inflection has been seen in managed care customers, outside Rx customers, and Progressive wearers, but overall traffic remains flat due to a depressed cash pay consumer.
Q:What is the expected contribution from pricing actions towards 2026?
A:The pricing actions taken in Q4, which include more surgical changes around lenses and lens packages, are expected to yield a similar contribution in 2026 as in 2025. The company is modernizing price points and evolving offers.
Q:How do pricing changes for 2026 impact contact lenses and ticket lift?
A:The company is taking pricing actions on ophthalmic lenses and contact lenses, with a quarter delay after cost increases from vendors. Ticket evolution is driven by pricing, assortment mix, and consumer mix components. The Q3 ticket lift of around 7% is not expected to replicate in 2026 due to lapping promotions from the previous year.
Q:What is the flow-through of the business as comps accelerate?
A:The company is focused on operating margin expansion, achieving 120 basis points of expansion year-to-date. They are investing in strategic initiatives while maintaining positive operating margins.
Q:What are the market share trends for the company?
A:The company believes it is gaining share on both a volume and dollar basis, outstripping exam growth in the category according to Vision Council data.
Q:What is the status of the cash pay consumer, and are there any changes in this cohort?
A:The cash pay consumer is showing slight acceleration in the purchase cycle and opting into higher-end frames and premium lens sales at higher rates than expected. The managed care consumer base is growing, and some cash pay consumers are transitioning to managed care customers.
Q:Are there any losses to competitors in the cash pay consumer base?
A:The company believes it is taking share from the category and does not see significant losses to competitors. The delayed purchase cycle of cash pay consumers is a category-wide issue.
Q:When will the price increase for exams to $95 take effect?
A:The price increase to $95 for an exam will take effect on the weekend of November 15-16.
Q:What is happening on the competitive front regarding pricing?
A:The category is generally growing on price rather than exam or customer count growth. National Vision is closing the gap on pricing compared to competitors while maintaining its value destination positioning.
Q:Are there any noteworthy regional differences in pricing?
A:There are no significant regional differences in pricing from a chain retail perspective.
Q:What are the trends in new customer acquisition and brand awareness?
A:Traffic growth is in the low teens for managed care, outside Rx, and Progressive wearers. Unaided brand awareness has grown by 19%, brand consideration by 10%, and creative copy scores have improved significantly since the brand relaunch.
Q:What changes are being made to CapEx for 2025 and 2026?
A:The decrease in CapEx guidance is due to timing, with some expenses shifting to 2026. There are no changes to strategic initiatives.
Q:What are the details of lens pricing actions and their impact on managed care customers?
A:Lens pricing actions include changes to coatings and lens materials, considering planned reimbursement rates and the division between plan pay and member out-of-pocket costs. The company is evolving its pricing architecture to be more sophisticated.
Q:Why is there a deceleration in Q4 implied comp growth?
A:The deceleration is due to lapping a promotion from the previous year and pragmatic expectations about consumer sentiment amidst macro uncertainty.
Q:What are the plans for Eyeglass World in terms of advertising and pricing?
A:Eyeglass World will undergo a replatforming in 2026, similar to America's Best. Early success has been seen with assortment and price evolution, and the brand is comping in the mid-single digits.
Q:What is the current managed care penetration rate?
A:Managed care penetration is growing in the low double digits, with a North Star goal of 50%. The company started the year at around 40% penetration.
Q:What are the gross margin trends and doctor availability?
A:Gross margin expansion in Q3 was driven by increased average ticket without needing more doctors. Doctor recruiting and availability are stable, with over 10% of the graduating class recruited annually.
Q:What is the performance of Meta glasses in pilot locations?
A:Meta glasses have exceeded expectations in the first 50 pilot locations, with plans to scale to an additional 250 stores.
Q:What are the advertising strategies for managed care customers?
A:The company is shifting from linear TV to more targeted digital assets like YouTube and Hulu to acquire managed care customers and improve brand consideration.
Q:What are the trends in health care costs and incentive compensation?
A:Health care costs have been a burden year-to-date, with Q3 seeing a disproportionate impact. Incentive compensation accruals are consistent with business performance and guide.
Q:What are the new store economic models and plans for 2026?
A:There are no material shifts in new store economics. Investments in marketing and CRM are expected to accelerate break-even timelines over time. More details will be shared at the Investor Day.
Q:What is the penetration rate of remote optometry services?
A:Remote optometry services are enabled in over 70% of locations, with further scaling limited by state regulatory constraints.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the flow-through of the business as comps accelerate, stating only that they are focused on operating margin expansion. They also did not provide clear specifics on regional pricing differences, stating there are generally no significant differences. Additionally, they avoided giving precise details on the impact of lens pricing actions on managed care customers' out-of-pocket costs, only mentioning that planned reimbursement rates were considered.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AOI expansion
Alex
CRM platform
Investor Day
Meta
President Investor
Vice President
add ons
associate
assortment
campaign
cost optimization
demonstration
doctor exam
engagement
evolution
flexibility
focus
frame
health care
lifestyle selling
merchandising
mix
number
offer pricing
pilot store
premium
price point
rate journey
response
selling approach
selling tool
store doctor
store end
store selling
traction
value segment
vision
work
EYE Transcript
National Vision Holdings, Inc. (EYE) Q1 2026 Earnings Call Transcript
Unknown5-13
Despite a 5% revenue increase and 10% net income growth, the decrease in gross margin and increased operating expenses indicate mixed financial health. The lack of strategic updates or operational insights, combined with generic risk statements, suggests uncertainty. The EPS growth and share repurchase activities provide some positives, but the overall sentiment remains neutral due to the absence of clear strategic direction or significant catalysts for stock movement.
National Vision Holdings, Inc. (EYE) Presents at Citi's 2026 Global Consumer & Retail Conference 2026 Transcript
Neutral3-9
National Vision Holdings, Inc. (EYE) Q4 2025 Earnings Call Transcript
Positive3-4
The earnings call summary and Q&A indicate positive sentiment with raised revenue expectations, strong managed care customer performance, and optimistic guidance. The introduction of smart eyewear and strategic marketing shifts are expected to drive growth. Cost management and store refreshes further support a positive outlook. Despite some uncertainties and conservative guidance, the overall sentiment leans towards positive with potential for stock price appreciation.
National Vision Holdings, Inc. (EYE) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Neutral12-3
EYE Slides
EYE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
